ReviewMarine drugs2024
Abiotic Factors Modulating Metabolite Composition in Brown Algae (Phaeophyceae): Ecological Impacts and Opportunities for Bioprospecting of Bioactive Compounds.
Review in Marine drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Suspect screening-based LC-HRMS characterization of short-chain peptide hydrolysates from marine macroalgae.Analytical and bioanalytical chemistry · 2026Article
- Review
- Enzymatic Hydrolysates fromMarine drugs · 2026Article
- Algae-Derived Bioactive Compounds as Platforms for Translational Biotechnology and Health Applications.Biotech (Basel (Switzerland)) · 2026Review
- Ethanolic Extract ofInternational journal of molecular sciences · 2026Article
- LC-HRMS-Based Metabolomic Profiling and Antioxidant Activity ofAntioxidants (Basel, Switzerland) · 2026Article
- Secret heroes of the sea: brown macroalgae and their bioactive powers-a narrative review.Frontiers in nutrition · 2026Review
- Nutritional composition, bioactive potential, andVeterinary world · 2025Article
- Use of Metabolomics Approach in the Discovery of Active Compounds from MacroalgaePharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Brown algae are vital structural elements and contributors to biodiversity in marine ecosystems. These organisms adapt to various environmental challenges by producing primary and secondary metabolites crucial for their survival, defense, and resilience. Besides their ecological role, these diverse metabolites have potential for biotechnological applications in industries including pharmaceuticals, cosmetics, and food. A literature review was conducted encompassing studies from 2014-2024, evaluating the effects of hydrodynamics, temperature, light, nutrients, seasonality, and salinity on the chemical profiles of various Phaeophyceae algae species. Thirty original articles spanning 69 species from the Sargassaceae, Dictyotaceae, Fucaceae, and Scytosiphonaceae families were analyzed and systematically arranged, with a focus on methodologies and key findings. This review furthers ecological discussions on each environmental factor and explores the biotechnological potential of metabolites such as polysaccharides, fatty acids, phenolics, diterpenes, and pigments. The information in this work is beneficial for metabolite bioprospecting and in vitro cultivation models as well as indoor and outdoor cultivation studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.